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Neither the early postnatal development of the liver Treg compartment nor the factors that regulate its development has been
characterized. We compared the early developmental patterns of Treg cell accumulation in murine liver, thymus, and spleen. A
FoxP3EGFP reporter mouse was employed to identify Treg cells. Mononuclear cells were isolated from organs postnatally, stained
for CD4, and examined by flow cytometry to enumerate FoxP3+ CD4hi cells. To assess roles for TGF-𝛽1, MyD88, and TLR2, genespecific knockout pups were generated from heterozygous breeders. To test the role of commensal bacteria, pregnant dams were
administered antibiotics during gestation and after parturition. The pattern of appearance of Treg cells differed in liver, spleen, and
thymus. Notably, at 1-2 weeks, the frequency of CD4hi FoxP3+ T cells in liver exceeded that in spleen by 1.5- to 2-fold. The relative
increase in liver Treg frequency was transient and was dependent upon TGF-𝛽1 and MyD88, but not TLR2, and was abrogated by
antibiotic treatment. A relative increase in liver Treg frequency occurs approximately 1-2 weeks after parturition that appears to be
driven by colonization of the intestine with commensal bacteria and is mediated by a pathway that requires TGF-𝛽1 and MyD88,
but not TLR2.

1. Introduction
The immune system is tightly regulated, maintaining, in
normal physiological conditions, a balance between immunity to challenge by pathogens and tolerance in order to
suppress inappropriate immune responses. Regulatory T
cells (Treg) have been recognized to play a major role
in immune homeostasis by maintaining self-tolerance and
preventing autoimmunity. Expression of the transcription
factor forkhead box P3 (FoxP3) specifies the Treg lineage
and confers suppressive function, through activation of a
transcriptional program required for regulation [1–3]. The
cytokine transforming growth factor beta1 (TGF-𝛽1) plays a
critical role in Treg development and function [4].
The liver can be considered an immune-privileged site
[5] similar to other immune-privileged organs such as the
eye and the gonads. The tolerogenic status of the liver is
necessary because the liver receives blood not only from

the systemic circulation via the hepatic artery, but also from
the gastrointestinal (GI) tract via the portal vein. Portal
vein flow results in a high concentration of non-pathogenassociated antigens reaching the liver, such as food antigens
and bacterial breakdown products from commensal organisms residing in the gut. For example, lipopolysaccharide
(LPS) is present in the portal venous blood at a concentration
of about 1 ng/mL [6], a concentration which, if present in the
systemic circulation, would lead to septic shock. To handle
this immense load of bacteria-derived substances, the liver
maintains a state of local immune tolerance, using a variety
of mechanisms [5, 7]. The liver Treg compartment is one
important component of the network of cells that mediates
liver tolerance [8, 9].
Toll like receptors (TLRs) are pathogen recognition
receptors that recognize conserved molecules found across
diverse bacterial species; for example, TLR2 recognizes
lipoteichoic acid present in most Gram-positive bacteria,
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whereas TLR4 recognizes LPS, present in most Gramnegative bacteria [10, 11]. TLRs play critical roles in linking
the innate and adaptive branches of the immune system.
TLR ligands induce dendritic cell (DC) maturation from
an immature phenotype and upregulate MHC class II and
costimulatory molecules, necessary for proper activation of
T cells by DCs [12]. Myeloid differentiation primary response
88 (MyD88) is a universal cytosolic adaptor protein that is
downstream of all bacterial-responsive TLRs.
While published studies have looked at the development
of Tregs in the neonatal thymus [13], and spleen [14], the
development of Tregs in the neonatal liver has not been
previously studied. Here, we assess the development of the
Treg compartment in the postnatal liver and examine the contributions of TGF-𝛽1 and MyD88 to liver Treg development.

2. Materials and Methods
2.1. Mice. FoxP3EGFP mice on the BALB/c background and
TLR2 knockout mice were obtained from the Jackson Laboratory (Bar Harbor, ME). FoxP3EGFP .Tgfb1−/− knockout mice
on the BALB/c background were generated by breeding
FoxP3EGFP with Tgfb1+/− heterozygous mice [15]. FoxP3EGFP
mice harbor a bicistronic FoxP3 locus that coexpresses eGFP
and FoxP3 [16]. The use of these reporter mice ensures
that native FoxP3 protein remains unmodified, as it has
been shown recently that a commonly used reporter mouse
expressing a FoxP3gfp fusion protein is a hypomorph with
an abnormal Treg phenotype [17]. MyD88 knockout mice
[18] were a kind gift from Dr. Brent Berwin at the Geisel
School of Medicine. Timed pregnant C57BL/6 mice were
obtained from the National Cancer Institute (NCI). Mice
were bred at the Geisel School of Medicine according to
Association for Assessment and Accreditation of Laboratory
Animal care practices. FoxP3EGFP and TLR2 knockout mice
were genotyped by PCR as per the vendors’ protocol. TGF-𝛽1
knockout mice and MyD88 knockout mice were genotyped
as previously described [19, 20], whereas Leadbetter et al.
[20] indicate that PCR products expected from Myd88+/+
mice and Myd88−/− mice are approximately 550 and 750
base pair (bp), respectively; in our hands these PCR products
were approximately 600 and 300 bp, respectively. The mouse
strain(s) (C57Bl/6 or BALB/c) used in each figure is indicated
in the figure legends.
2.2. Isolation of Mononuclear Cells from Organs. Cardiac
perfusion was carried out before removal and weighing
of organs. Liver tissue was dissociated by chopping using
a razor blade or by use of a tissue dissociator as per
manufacturer’s protocol (gentleMacs dissociator, Miltenyi
Biotec) and subjected to treatment with 5 𝜇g DNAse and
500 Units of Collagenase (Sigma). A cell suspension of liver
nonparenchymal cells (NPC) was obtained by filtering and
removal of hepatocytes, followed by red blood cell (RBC)
lysis. For spleen and thymus, cell suspensions were prepared
by grinding between frosted glass slides, followed by filtering
and RBC lysis.
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2.3. Flow Cytometry. Prior to staining with specific antibody,
nonspecific binding was blocked using Fc block (anti-mouse
CD16/CD32, clone 93, eBioscience). Antibodies used for
staining were anti-CD4 (clone GK1.5, eBioscience), anti-CD3
(clone 145-2C11, BD Pharmingen), and anti-FoxP3 (clone
FJK-16s, eBioscience). Intracellular staining for FoxP3 was
carried out using a kit according to the manufacturer’s protocol (eBioscience). Cell staining was acquired on either FACS
Calibur or BD Accuri C6. Flow data analysis was carried out
using either FlowJo version 7.6.5 (TreeStar) software or BD
Accuri C6 software (Version 1.0.202.1).
2.4. Antibiotic Treatment. Timed pregnant mice were treated
beginning at about two weeks of gestation with the following antibiotics (in the drinking water): ampicillin (1 g/L),
neomycin sulfate (1 g/L), metronidazole (1 g/L), and vancomycin (0.5 g/L). Sucrose (10 g/L) was also added to the
water. Antibiotic treatment in the drinking water was maintained until pups were 8-9 days old. Antibiotic water was
changed twice weekly.
2.5. Statistics. Significance was determined using either the
nonparametric Mann Whitney 𝑈-test for two-group comparisons or a two-way ANOVA for kinetic data. Statistical
analyses were carried out using GraphPad Prism software
(Version 6.0). Significance is denoted as follows: ns not
significant (𝑃 > 0.05), ∗ 𝑃 ≤ 0.05, ∗∗ 𝑃 ≤ 0.01, ∗∗∗ 𝑃 ≤ 0.001,
∗∗∗∗
𝑃 ≤ 0.0001, or as indicated in the figures. Error bars
indicate mean ± standard deviation. Box and whisker plots
show 5th to 95th percentile.

3. Results
3.1. Postnatal Development of FoxP3+ CD4ℎ𝑖 T Cells in Thymus,
Spleen, and Liver. We employed a reporter mouse that provides convenience in the detection of FoxP3 expressing cells
[16]. In FoxP3EGFP transgenic reporter mice, FoxP3 expressing cells are identified as eGFP+ and are readily detected on
flow cytometry without needing additional manipulations,
such as intracellular staining. It has been shown recently that
transgenic mice in which the eGFP reporter is expressed as a
fusion protein with FoxP3 have subtle immunologic abnormalities, owing to unexpected effects of the eGFP fusion
partner on FoxP3 functionality [17]. For this reason, we used
reporter mice in which the FoxP3 protein is expressed from
a bicistronic reporter construct that coexpresses FoxP3 and
eGFP as separate proteins [16]. We obtained evidence that the
expression of GFP is a reliable marker for FoxP3 expression.
Using cell sorting to isolate GFP+ and GFP− populations, we
analyzed sorted populations by intracellular staining for the
nuclear protein FoxP3 (Figure 1). The GFP− population did
not show expression of FoxP3, whereas greater than 95% of
the GFP+ population was positive for the expression of FoxP3.
Next, we assessed the development of FoxP3+ CD4hi T
cells (regulatory T cells (Tregs)) in early postnatal thymus,
liver, and spleen of FoxP3EGFP reporter mice. We assessed
both the frequency of Tregs, defined as the percentage of
Tregs (GFP+ or FoxP3+ ) among CD4hi T cells, and the density
of Tregs in each organ, defined as Treg cells/mg.
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Figure 1: GFP expression is a reliable marker of FoxP3 expression in liver CD4+ cells from FoxP3EGFP transgenic reporter mice. NPC were
isolated from liver of adult BALB/c-background FoxP3EGFP mice and CD4+ cells were sorted by GFP expression. Sorted cell populations were
then analyzed by intracellular staining for FoxP3 expression.

Previous studies show that Tregs are detectable in thymus
at postnatal days 3-4 [13, 21]. Consistent with this, about 3%
of CD4hi cells in FoxP3EGFP mouse thymus were GFP+ at
postnatal days 3-4 (Figures 2(a) and 2(b)). Over the next
two to three weeks, the frequency of GFP+ cells among
CD4hi cells progressively decreased to ∼1% by weaning
age (day 20-21). The density of Tregs in thymus remained
relatively constant throughout the neonatal period (range
1,200 to 4,000 cells/mg; Figure 2(c)). In this analysis, we
did not specifically stain for CD8 and therefore cannot
formally determine whether some of these cells represent

CD4CD8 double positive (DP) cells. However, this percentage is likely to be quite small, as it has been shown in
several previous studies that, in the postnatal period through
adulthood, greater than 95% of CD4+ FoxP3+ thymocytes
are CD4hi CD8neg single positive cells and less than 5% of
CD4+ FoxP3+ thymocytes are DP cells [13, 22].
In spleen, the frequency of Tregs was ∼6% at days 3-4
and quickly increased, reaching a steady state of ∼10–12% at
days 6–8, a frequency maintained at 11-12 days and 20-21 days
(Figures 2(a) and 2(b)). The density of Tregs in the spleen
was 500 cells/mg at days 3-4 and progressively increased over
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Figure 2: Postnatal development of FoxP3+ CD4+ cells in thymus, spleen, and liver. NPC were isolated from thymus, spleen, and liver of
BALB/c-background FoxP3EGFP transgenic reporter mice of the indicated ages. (a) Individual GFP expression profiles of CD4+ T cells are
shown. (b) Composite data from several mice are shown. Frequency indicates the percentage of CD4+ T cells that coexpress eGFP as a
reporter of FoxP3 expression. 𝑁 = 3 to 8 mice per time point. (c) Composite data from several mice are shown. Density indicates the number
of CD4+ eGFP+ cells per wet weight of the organ. 𝑁 = 3 to 8 mice per time point.
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Figure 3: The increased frequency of FoxP3+ CD4+ cells in postnatal liver reverses in the adult. (a) Liver and spleen FoxP3+ CD4+ frequency
data from BALB/c-background FoxP3EGFP mice prior to weaning are displayed. Statistical analysis was by 2-way ANOVA. (b) FoxP3+ CD4+
frequency data from preweaned mice (age 1-2 weeks) and adult mice (age 6 weeks; age 13.5 weeks) are shown. For 1-2 weeks, data for 6to 8-day-old mice were combined with data from 11- to 12-day-old mice. 𝑁 = 7 to 12 mice per time point. Statistical analyses used the
nonparametric Mann-Whitney test.

the next several weeks. By weaning age, splenic Treg density
increased significantly, to ∼6,500 cells/mg (Figure 2(c)).
In liver, Tregs were detectable as early as days 3-4, with
a frequency (∼6%) comparable to that of spleen at similar
age. At days 6–8 and 11-12, approximately 15–17% of CD4hi
T cells were Tregs. At days 20-21, the frequency was lower
(13%; Figures 2(a) and 2(b)). At all ages tested, the density
of Tregs in liver was lower than in either spleen or thymus
(Figure 2(c)), consistent with the lower numbers of immune
cells in this nonlymphoid organ.
A direct comparison of Treg frequency in the two organs
shows that the spleen and liver were comparable at days 34 and 20-21. However, in between these two time points,
the liver exhibited a significantly greater (∼1.5-fold) Treg
frequency (Figure 3(a)). Statistical analysis using ANOVA
revealed that these curves are significantly different (𝑃 =
0.003). Assessing later time points, at 6 weeks, the relative
frequency of Tregs in liver was lower than in spleen, a
difference that was even more pronounced at 13.5 weeks
(Figure 3(b)). Thus, at 1-2 weeks of age, the liver exhibits a
relatively greater Treg frequency as compared with spleen; in
the mature adult, the relative frequency is reversed, with liver
showing lower Treg frequency among CD4hi T cells.
3.2. TGF-𝛽1 Is Required for the Normal Pattern of Development
of FoxP3+ CD4ℎ𝑖 T Cells in Thymus, Spleen, and Liver. Because
TGF-𝛽1 plays an important role in the ontogeny and function

of Tregs, we analyzed its contribution to the early development of Tregs in thymus, spleen, and liver. To facilitate
this analysis, we crossed BALB/c background FoxP3EGFP
mice with BALB/c background TGF-𝛽1 knockout (Tgfb1−/− )
mice [15]. BALB/c Tgfb1−/− mice develop histologically and
biochemically detectable necroinflammatory disease in liver
and other organs beginning at around 10 days of age, caused
by an influx of CD4+ T cells [23], and die at 15–17 days of
age. Owing to this lethality, we could not measure Tregs at
20-21 days, so our analyses here are restricted to the 3-4, 6–8,
and 11-12 day time points only. FoxP3EGFP littermates with one
intact Tgfb1 allele (heterozygous Tgfb1+/− mice) were used
as controls; Tgfb1+/− mice are healthy and phenotypically
indistinguishable from wild type (Tgfb1+/+ ) mice [19].
In thymus, Treg frequency in control Tgfb1+/− mice was
∼4% at days 3-4 and diminished moderately over the next
week (Figure 4(a)), indicating that the control mice exhibited
the expected WT FoxP3EGFP mouse pattern (Figure 2). In
Tgfb1−/− mice at days 3-4, thymic Treg frequency was lower
than in littermate Tgfb1+/− mice. The Treg frequency in
Tgfb1−/− thymus increased dramatically over the next week,
reaching 10% at days 11-12 (Figure 4(a)). The density of
Tregs also increased in Tgfb1−/− thymus over this time
period (Figure 4(b)). The dramatic increase in thymic Treg
production at days 6–8 and 11-12 is consistent with previous
reports showing a similar pattern in mice in which T cells
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Figure 4: The increased frequency of FoxP3+ CD4+ cells in postnatal liver depends on TGF-𝛽1. NPC were isolated from thymus, spleen, and
liver of BALB/c-background FoxP3EGFP .Tgfb1+/− mice and littermate FoxP3EGFP .Tgfb1−/− mice at the indicated ages. (a) Frequency data for
FoxP3+ CD4+ cells are shown. (b) Density data for FoxP3+ CD4+ cells are shown. (c) Data for spleen and liver are shown for Tgfb1+/− mice
and Tgfb1−/− mice. 𝑁 = 4 to 9 mice per group at each time point. Statistical analyses were by 2-way ANOVA.
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have been rendered conditionally deficient in one of the key
components of the TGF-𝛽 receptor [21, 24].
In spleen, Treg frequency in control Tgfb1+/− mice exhibited the expected WT FoxP3EGFP mouse pattern; that is, Treg
frequency was ∼7% at days 3-4 and increased to a steady state
of ∼12 to 13% over the next week. Tgfb1−/− mice exhibited a
significant delay in the development of Tregs in the neonatal
spleen; at days 3-4 and 6–8, both frequency and density of
Tregs in Tgfb1−/− spleen were significantly lower compared
to Tgfb1+/− littermates. By days 11-12, there was no difference
in either frequency or density between Tgfb1−/− spleens and
Tgfb1+/− spleens (Figures 4(a) and 4(b)).
In liver, Treg frequency in control Tgfb1+/− mice was ∼
10% at days 3-4 and increased to over 20% over the next
week, an increase similar to that observed in WT FoxP3EGFP
liver. As in spleen, Tgfb1−/− liver exhibited a significant delay
in the development of Tregs; at days 3-4, the frequency of
Tregs in Tgfb1−/− liver was significantly lower compared to
littermate control Tgfb1+/− livers. At days 11-12, the frequency
of Tregs among CD4+ T cells in Tgfb1−/− liver remained low
(Figure 4(a)). This is a different pattern from that observed
in Tgfb1−/− spleen, where the frequency of Tregs normalized
by days 11-12. The low Treg frequency at day 11-12 is likely a
function of the massive influx of (non-Treg) effector CD4+ T
cells into liver (but not spleen) that occurs just prior to 11 days
of age in Tgfb1−/− mice [23]. Indeed, at days 11-12, the absolute
density of Tgfb1−/− liver Tregs surpassed that of littermate
control Tgfb1+/− liver Tregs, consistent with a large overall T
cell influx (Figure 4(b)).
Next, we examined these data to test the hypothesis that
TGF-𝛽1 is required for the transient increase in liver Tregs
observed at 1-2 weeks of age. We compared the frequency of
Tregs in liver with the frequency of Tregs in spleen in Tgfb1−/−
mice, as well as in littermate control Tgfb1+/− mice. At days 1112, littermate control Tgfb1+/− mice had a significantly higher
frequency of Tregs in liver as compared with spleen (𝑃 < 0.01
by ANOVA; Figure 4(c)), similar to what had been observed
in WT FoxP3EGFP mice. Importantly, in Tgfb1−/− mice at any
age, Treg frequency was no different in spleen versus liver (𝑃:
n.s.). Therefore, the transient increase in liver Treg frequency
observed in the postnatal period requires TGF-𝛽1.
3.3. Commensal Bacteria and MyD88 Are Required for the
Increase in Liver Treg Frequency in the Early Postnatal Period.
We sought to further understand the factors that contribute
to the transient increase in frequency of liver Tregs that
occurs one week after parturition. We considered that the
transient increase might represent a response to postnatal
colonization of the murine intestine. Commensal organisms
begin to colonize the murine intestinal tract as early as
day 1 after birth [25]. The intestinal microbiota is known
to play an important role in shaping the mature immune
system in the intestine as well as extraintestinally [26]. Based
on the anatomic relationship between the intestine and the
liver, it is reasonable to conjecture that the gut-liver axis is
important for the establishment of the immune system in the
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liver. We attempted to experimentally manipulate commensal
colonization by treating pregnant dams with a cocktail of
antibiotics before and after delivery. We obtained data from
two litters in which the mothers had been treated successfully
with oral antibiotics. Indeed, treatment with oral antibiotics
abrogated the transient increase in liver Tregs (Figure 5(a)).
In general, however, treatment with antibiotics resulted in
unexpected and unacceptable morbidity and poor maternal
behavior in mothers (not shown), so we took an orthogonal
approach to test our hypothesis.
We hypothesized that the transient postnatal increase
in liver Treg frequency is dependent on signals emanating
from TLR responses to bacterial products. Since MyD88
is a common adaptor molecule that mediates downstream
signaling from all bacterial responsive TLRs, we hypothesized
that MyD88 is required for the transient postnatal increase in
liver Treg frequency. We tested this hypothesis by examining
Treg frequency in mice deficient in MyD88. We interbred
heterozygous Myd88+/− mice to produce littermate Myd88+/+
pups, Myd88+/− pups, and Myd88−/− pups. Importantly, a
recent study shows that Myd88 gene status does not affect
colonization of the intestine by commensal organisms [27];
therefore all mice from the same litter should become
colonized with similar microbiota at similar concentrations,
removing a potential artifact in interpretation of data. We
analyzed mice at a time point (days 8-9) at which the
difference in frequency between spleen Treg and liver Treg
is expected to be maximal. Because these mice do not harbor
the FoxP3EGFP reporter construct, we directly analyzed intracellular FoxP3 expression on flow cytometry. As expected,
wild type Myd88+/+ pups had a higher frequency of Treg cells
in liver than in spleen. Notably, the increase in liver Treg
frequency at this age was completely abrogated in Myd88−/−
pups, which had the same frequency of Treg cells in liver as
in spleen (Figure 5(b)). Myd88+/− livers also showed a relative
increase in liver Treg frequency, but this was more modest
than in their wild type Myd88+/+ littermates, suggesting there
is a gene dosage effect in this pathway. Thus, MyD88 is
required for the transient increase of Treg frequency seen
in murine liver at 1-2 weeks of age, strongly supporting the
hypothesis that the increase in Treg frequency in liver is a
response to colonization of the gut by commensal organisms.
3.4. TLR2 Is Not Required for the Increase of Postnatal Liver
Treg. As MyD88 is required for appropriate neonatal Treg
development in liver, we next sought to identify upstream
signaling molecule(s) that may be required for detection
of gut colonization. TLR2 has been shown to be required
for induction and upregulation of Tregs in mice [28, 29].
Moreover, TLR2 deficient mice exhibit a 50% decrease in the
frequency of circulating Treg cells, whereas TLR4 deficient
mice have normal Treg frequency [30, 31]. We therefore
hypothesized that TLR2 is required for the transient increase
of Treg frequency in murine liver during early development.
We tested this hypothesis by examining Treg frequency in
the liver and spleen of TLR2 deficient pups. As expected,
Tlr2+/+ mice had a higher frequency of Treg cells in liver
than in spleen (analyzed at days 8-9). Tlr2−/− mice also had a
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Figure 5: The increased frequency of FoxP3+ CD4+ cells in postnatal liver is blocked by treatment with antibiotics and depends on MyD88. (a)
Pregnant C57Bl/6 females were treated continuously with a cocktail of oral antibiotics from two weeks of gestation until pups were 8-9 days
of age, at which time spleen and liver NPC were isolated and FoxP3+ CD4+ cells were measured (𝑛 = 13 mice). Control mice are untreated
C57Bl/6 background pups of the same age (𝑛 = 4 mice). Statistical analyses used the nonparametric Mann-Whitney test. (b) Liver and spleen
FoxP3+ CD4+ cell frequency data are shown for 8- to 9-day-old littermate Myd88+/+ mice, Myd88+/− mice, and Myd88−/− mice. 𝑁 = 8 to 13
mice per time point. Myd88 mice were on a mixed BALB/c × C57Bl/6 background, but littermates were used, minimizing background effects.
Statistical analyses used the nonparametric Mann-Whitney test.

higher frequency of Treg cells in liver than in spleen and were
indistinguishable in this regard from their Tlr2+/+ littermates
(Figure 6). Thus, TLR2 is not required for the transient
increase in Treg frequency. The involvement of MyD88 in this
response may be downstream of a different TLR, or perhaps
a combination of TLRs.

While previous reports have studied the development of
Tregs in the neonatal thymus [13], nothing is known about
the development of this important T cell compartment in
the neonatal liver. This study reveals that the development
of the Treg compartment in the liver starts as early as day 3
after birth and that there is a pattern of a transient increase
in the percentage of Tregs in the liver between days 6 and
days 12. This pattern of development of postnatal liver Tregs
requires TGF-𝛽 as well as MyD88. Colonization of the gut by
commensal bacteria is seen as early as day 1 after birth [25].
It has been shown previously that the intestinal colonization
of germ-free mice leads to the induction, activation, and
expansion of mucosal Tregs [32] and the maintenance of
immune homeostasis. Since the liver receives approximately
70% of its blood flow via the portal vein from the gut, the
gut-liver axis plays a very important role in modulating the
immune microenvironment of the liver.
Based on these previous observations and our findings
here, we propose a model for liver Treg development.
Microbial colonization of the intestine may be detected by
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Figure 6: The increased frequency of FoxP3+ CD4+ cells in postnatal
liver is independent of TLR2. Liver and spleen FoxP3+ CD4+ cell
frequency data are shown for 8- to 9-day-old littermate C57Bl/6background Tlr2+/+ mice and Tlr2−/− mice. 𝑁 = 4 to 5 mice
per genotype. Statistical analyses used the nonparametric MannWhitney test.
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intestinal cells by one or more TLR signaling pathways,
mediated by the downstream adaptor molecule MyD88.
The colonization of the gut also leads to the production
of TGF-𝛽1. Expression of TGF-𝛽 isoforms and receptors
is detectable in rat gastric epithelium both during fetal
development and in the neonatal stage [33]. In a model of
induction of colonic Tregs with Clostridium species, it has
been shown that, upon TLR ligation, intestinal epithelial
cells increase TGF-𝛽1 production and upregulate expression
of matrix metalloproteinases (MMP2, MMP9, and MMP13)
that hydrolyze latent TGF-𝛽, converting it to its active form
[34]. We propose that TLR/MyD88-mediated response to
microbial colonization in the intestine enhances production
of TGF-𝛽1, resulting in an increase in Treg percentage in
the liver. The observed transient increase in neonatal liver
Tregs may result from expansion of Tregs within liver itself,
or from an increased influx of Tregs from the intestine;
the data presented here neither support nor exclude either
possibility. TGF-𝛽1 might act in the intestine to recruit naı̈ve
intestinal T cells along the Treg developmental pathway
or cause expansion of an existing Treg population, which
then traffic to the liver. Alternatively, microbial products
resulting from gut colonization reaching the liver via the
portal vein might only then be detected by TLRs expressed
by resident liver cells. TLR expression in the liver is observed
in several different cell populations, including Kupffer cells,
hepatocytes, hepatic stellate cells, LSECs, hepatic dendritic
cells, and liver NK cells [35, 36]. Interestingly, TLR4 ligation
of quiescent HSCs results in increased expression of Bambi,
the pseudoreceptor for TGF-𝛽, increasing the sensitivity of
HSCs to TGF-𝛽 [37].
TGF-𝛽1 is critical for the development and maintenance
of Treg cells in the thymus as well as in the periphery [4].
TGF-𝛽1 is critical for the complete development of liver
Tregs, since the increase in liver Tregs observed at one
week postnatally is abrogated in mice deficient in the gene
encoding TGF-𝛽1. It has been shown that TGF-𝛽1 may be
acquired from the mother through breast-feeding [38] and
pups here are indeed born from TGF-𝛽1-replete mothers
(Tgfb1 heterozygous); moreover, there are two additional
TGF-𝛽 isoforms expressed in mouse. Clearly, however, it is
endogenously produced TGF-𝛽1 that is critical for the Treg
increase at one week after birth, and neither maternal TGF𝛽1 nor endogenous TGF-𝛽2 or TGF-𝛽3 is sufficient to rescue
the liver Treg development phenotype.
In addition to TGF-𝛽1, several additional secreted or
membrane-bound factors are known to affect Treg development, including IL-2, retinoic acid and B-7 family molecules
that signal through CD28 and CTLA-4 [39, 40]. It will
be interesting to determine which, if any, of these factors
participates in the regulation of liver Treg development and
how they may interact with TGF-𝛽1 and TLR/MyD88 to
influence the liver Treg compartment.
Commensal bacteria play important roles in shaping the
immune system [26, 41]. As previously noted, the presence or
absence of an intact TLR/MyD88 response axis does not affect
microbiota composition in steady state, and in fact maternal
origin and vertical transmission are the important factors
that define the structure of the microbiota in colonies of TLR
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knockout mice and MyD88 knockout mice [27]. In humans,
it has been shown that maternal exposure to agriculture
increases Tregs in cord blood, which might later affect allergic
responses [42]. Our data using antibiotic treatment in wildtype mice, and the use of MyD88 deficient mice, suggest that
commensals also contribute to shaping the composition of
liver resident immune cells, specifically the Treg compartment. While MyD88 is a common adaptor molecule for all the
bacterial responsive TLRs, it is also important in downstream
signaling from IL-1R [43], and this pathway cannot be ruled
out; however, the results of the antibiotics experiments argue
that the relevant role of MyD88 is downstream of one or
more TLRs. In our attempts to identify which TLR may be
involved, we focused on TLR2 because of its defined role in
Treg development [28, 29]. We found that TLR2 alone was
dispensable for the Treg development pattern in the liver. The
roles of other TLRs remain to be investigated.
Differential composition of the microbiota within the
same genetic mouse strain, but obtained from different
vendors, has been shown to result in differential development
of the immune system [44, 45]. In this study we used mice
bred in our animal facility, so we are not able to comment on
whether differences in microbiota might differentially affect
Treg development in the liver. We also do not know if the
pattern of Treg development observed in liver is in response
to one or more specific bacterial taxa, or if it represents a
response to polymicrobial gut colonization.
It will be important to determine whether the transient
increase in neonatal liver Treg frequency contributes to establishing proper liver immune cell function and if this increase
in Treg frequency is important for the development of liver
tolerance. A recent study using gene expression profiling has
shown that exposure to microbiota in the neonatal period is
essential for appropriate TLR responses, whose later exposure
does not restore appropriately [41]. In this context, the timing
of the increased liver Treg frequency may be important for
establishing immune tolerance.
It is notable that the frequency of liver Tregs is very
high one week after birth but then declines markedly; in
the adult, the frequency of liver Tregs is much lower than
the frequency of splenic Tregs. Presumably, as the frequency
of liver Tregs declines, other tolerogenic pathways begin to
have greater effect in maintaining the generally tolerogenic
state of the liver. Such pathways likely include, as detailed
in a comprehensive review by Crispe [5], expression of
adhesion molecules to trap effector T cells in liver sinusoids,
an abundance of immunosuppressive cytokines such as IL10 and TGF-𝛽, the expression of inhibitory T cell checkpoint
molecules such as PD-L1, and the induction of apoptosis
on T cells mediated by death ligands such as FasL that are
expressed on various liver nonparenchymal cells, such as
Kupffer cells.

5. Conclusion
In conclusion, our data suggest an important role for intestinal microbial colonization in the development of the liver
Treg compartment. This might be important in the establishment of liver tolerance, and interruption or alteration
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of this physiologic event might contribute to inflammatory
liver disease. In light of these studies, it is worthwhile to
consider whether there may be a relationship between the
use of antibiotics in the neonatal period and the subsequent
development of inflammatory liver disease later in life.
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E. R. de Andrade Sá, L. R. Jordão, C. A. Takahashi, E. P. Alvares,
and P. Gama, “Ontogenic expression of TGFbeta 1, 2, and 3
and its receptors in the rat gastric mucosa,” Developmental
Dynamics, vol. 227, no. 3, pp. 450–457, 2003.
K. Atarashi, T. Tanoue, T. Shima et al., “Induction of colonic
regulatory T cells by indigenous Clostridium species,” Science,
vol. 331, no. 6015, pp. 337–341, 2011.
E. Seki and D. A. Brenner, “Toll-like receptors and adaptor
molecules in liver disease: update,” Hepatology, vol. 48, no. 1,
pp. 322–335, 2008.
A. E. Bigorgne and I. N. Crispe, “TLRs in hepatic cellular
crosstalk,” Gastroenterology Research and Practice, vol. 2010,
Article ID 618260, 7 pages, 2010.
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